Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjects

Dementia and Geriatric Cognitive Disorders

Volumn 32, Issue 2, 2011, Pages 135-142

  Norberg, J ^a,b   Graff, C ^a   Almkvist, O ^a,b   Ewers, M ^d,g   Frisoni, G B ^h   Frolich L ^e   Hampel, H ^f   Jones, R W ^j   Kehoe, P G ^k   Lenoir, H ^m   Minthon, L ^c   Nobili, F ⁱ   Olde Rikkert, M ^o   Rigaud, A S ^m   Scheltens, P ^p   Soininen, H ^r   Spiru, L ^s   Tsolaki, M ^t   Wahlund, L O ^a   Vellas, B ⁿ   Wilcock, G ^l   Elias Sonnenschein, L S ^q   Verhey, F R J ^q   Visser, P J ^p,q   more..

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f GOETHE UNIVERSITY   (Germany)

^g ADELAIDE AND MEATH HOSPITAL   (Ireland)

^h IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

ⁱ UNIVERSITY OF GENOA   (Italy)

^j Research Institute for the Care of Older People (RICE)   (United Kingdom)

^k UNIVERSITY OF BRISTOL   (United Kingdom)

^l UNIVERSITY OF OXFORD   (United Kingdom)

^m Paris Descartes University   (France)

ⁿ TOULOUSE UNIVERSITY HOSPITAL   (France)

^o RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^p VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^q MAASTRICHT UNIVERSITY   (Netherlands)

^r KUOPIO UNIVERSITY HOSPITAL   (Finland)

^s CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^t ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

more..

Author keywords

Alzheimer's disease; APOE 4 allele; Europe; Gradient

Indexed keywords

APOLIPOPROTEIN E4;

ALLELE; ARTICLE; COGNITIVE DEFECT; EUROPE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; LANGUAGE; LEARNING; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; RECALL; VERBAL MEMORY;

APOLIPOPROTEINS E; COGNITION; COGNITION DISORDERS; DEMENTIA; EUROPE; GENE FREQUENCY; HUMANS; REFERENCE VALUES; TOPOGRAPHY, MEDICAL;

EID: 80054863058     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000330492     Document Type: Article

References (46)

1. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 5123: 921-923. (Pubitemid 23275809)
2. Mariani E, Monasero R, Mecocci P: Mild cognitive impairment: a systematic review. J Alzheimers Dis 2007; 1: 23-35. (Pubitemid 47396302)
3. Lautenschlager NT, Flicker L, Vasikaran S, Leedman P, Almeida OP: Subjective memory complaints with and without objective memory impairment: relationship with risk factors for dementia. Am J Geriatr Psychiatry 2005; 8: 731-734. (Pubitemid 41197245)
4. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad, B: Current concepts in mild cognitive impairment. Arch Neurol 2001; 12: 1985-1992. (Pubitemid 33143977)
5. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC: Mild cognitive impairment: beyond controversies, towards a consensus. J Intern Med 2004; 3: 240-246.
6. Panza F, Solfrizzi V, Torres F, Mastroianni F, Del Parigi A, Colacicco AM, Basile AM, Capurso C, Noya R, Capurso A: Decreased frequency of apolipoprotein Eα 4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians. Neurosci Lett 1999; 277: 53-56.
7. Lucotte G, Loirat F, Hazout S: Pattern of gradient of apolipoprotein E allele *4 frequencies in Western Europe. Hum Biol 1997; 2: 253-262. (Pubitemid 27133960)
8. Tiret L, de Knijff P, Menzel HJ, Ehnholm C, Nicaud V, Havekes LM: ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS study. European Arteriosclerosis Research study. Arterioscler Thromb 1994; 10: 1617-1624.
9. Schiele F, De Bacquer D, Vincent-Viry M, Beisiegel U, Ehnholm C, Evans A, Kafatos A, Martins MC, Sans S, Sass C, Visvikis S, De Backer G, Siest G: Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis 2000; 152: 475-488.
10. Corbo RM, Scacchi R: Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele? Ann Hum Genet 1999; 4: 301-310. (Pubitemid 30021229)
11. Murman DL, Foster NL, Kilgore SP, Mc- Donagh CA, Fink JK: Apolipoprotein E and Alzheimer's disease: strength of association is related to age at onset. Dementia 1996; 5: 251-255. (Pubitemid 26278684)
12. Ramakers IH, Visser PJ, Aalten P, Bekers O, Sleegers K, van Broeckhoven CL, Jolles J, Verhey FR: The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology. Dement Geriatr Cogn Disord 2008; 2: 101-108.
13. Fleisher A, Grundman M, Jack CR Jr, Petersen RC, Taylor C, Kim HT, Schiller DH, Bagwell V, Sencakova D, Weiner MF, DeCarli C, DeKosky ST, van Dyck CH, Thal LJ: Sex, apolipoprotein Eα 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol 2005; 6: 953-957. (Pubitemid 40973457)
14. Visser PJ, Verhey FR, Boada M, Bullock R, De Deyn PP, Frisioni GB, Frolich L, Hampel H, Jolles J, Jones R, Minthon L, Nobili F, Olde Rikkert M, Ousset PJ, Rigaud AS, Scheltens P, Soininen H, Spiru L, Touchon J, Tsolaki M, Vellas B, Wahlund LO, Wilcock G, Winblad B: Development of screening guidelines and clinical criteria for predementia Alzheimer's disease: the DESCRIPA study. Neuroepidemiology 2008; 4: 254-265. (Pubitemid 351871657)
15. Folstein MF, Folstein SE, McHugh PR: 'Mini-Mental State': A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 3: 189-198.
16. Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 11: 2412-2414. (Pubitemid 23346995)
17. Reisberg B, Ferris SH, de Leon MJ, Crook T: The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 9: 1136-1139. (Pubitemid 12051593)
18. Lezak MD, Howieson DB, Loring DW: Neuropsychological Assessment, ed 4. New York, Oxford University Press, 2004.
19. Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, Heyman A: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology 1994; 4: 609-614. (Pubitemid 24129983)
20. Grober E, Buschke H, Crystal H, Bang S, Dresner R: Screening for dementia by memory testing. Neurology 1988; 6: 900-903.
21. Masur DM, Fuld PA, Blau AD, Thal LJ, Levin HS, Aronson MK: Distinguishing normal and demented elderly with the selective reminding test. J Clin Exper Neuropsychol 1989; 5: 615-630. (Pubitemid 19271845)
22. Aebi C: Validierung der neuropsychologischen Testbatterie CERAD-NP. Basel, Universität Basel, 2002.
23. Brandt J: The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychol 1991; 2: 125-142.
24. van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J: Normative data for the Animal, Profession and Letter M naming verbal fluency tests for Dutch speaking participants and the effects of age, education, and sex. J Int Neuropsychol Soc 2006; 1: 80-89. (Pubitemid 43379954)
25. Novelli G: Three clinical tests for the assessment of lexical retrieval and production. Norms from 320 normal subjects. Arch Psicol Neurol Psichiatr 1986; 47: 477-506.
26. Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A: Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol Sci 2002; 6: 443-447. (Pubitemid 34436807)
27. Carlesimo GA, Caltagirone C, Gainotti G: The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 1996; 6: 378-384. (Pubitemid 26343685)
28. Warrington E, James M: Cube analysis test of the Visual Object and Space Perception battery 70. The Visual Object and Space Perception Battery. London, Harcourt Assessment, 1991.
29. Reitan R: Validity of the Trail Making Test as an indicator of organic brain damage. Percep Motor Skill 1958; 8: 271-276.
30. Ingelsson M, Shin Y, Irizarry MC, Hyman BT, Lilius L, Forsell C, Graff C: Genotyping of apolipoprotein E: comparative evaluation of different protocols. Curr Protoc Hum Genet 2003; 9: 9-14.
31. Dik MG, Jonker C, Bouter LM, Geerlings MI, van Kamp GJ, Deeg DJ: APOE-epsilon4 is associated with memory decline in cognitively impaired elderly. Neurology 2000; 7: 1492-1497. (Pubitemid 30210473)
32. Farlow MR, He Y, Tekin S, Xu J, Lane R, Charles HC: Impact of APOE in mild cognitive impairment. Neurology 2004; 10: 1898-1901. (Pubitemid 39532387)
33. Feldman HH., Ferris S, Winblad B, Sfikas N, Mancione L, He Y, Tekin S, Burns A, Cummings J, del Ser T, Inizitiari D, Orgogonzo JM, Sauer H, Scheltens P, Scarpini E, Herrman N, Farlow M, Potkin S, Charles HC, Fox NC, Lane R: Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol 2007; 6: 501-512. (Pubitemid 46738627)
34. Corella D, Tucker K, Lahoz C, Coltell O, Cupples LA, Wilson PW, Schaefer EJ, Ordovas JM: Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study. Am J Clin Nutr 2001; 73: 736-745. (Pubitemid 32239228)
35. Erkkilä AT, Sarkkinen ES, Lindi V, Lehto S, Laakso M, Uusitupa MI: APOE polymorphism and the hypertriglyceridemic effect of dietary sucrose. Am J Clin Nutr 2001; 73: 746-752. (Pubitemid 32239229)
36. Bretsky PM, Buckwalter JG, Seeman TE, Miller CA, Poirier J, Schellenberg GD, Finch CE, Henderson VW: Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis Assoc Disord 1999; 13: 216-221. (Pubitemid 30011379)
37. Zimprich D, Martin M, Kliegel M: Subjective cognitive complaints, memory performance, and depressive affect in old age: a changeoriented approach. Int J Aging Hum Dev 2003; 4: 339-366. (Pubitemid 38623659)
38. Kliegel M, Zimprich D, Eschen A: What do subjective cognitive complaints in persons with aging-associated cognitive decline reflect? Int Psychogeriatr 2005; 3: 499-512. (Pubitemid 41391693)
39. van der Flier WM, Pijnenburg YA, Schoonenboom SN, Dik MG, Blankenstein MA, Scheltens P: Distribution of APOE genotypes in a memory clinic cohort. Dement Geriatr Cogn Dis 2008; 5: 433-438. (Pubitemid 351630076)
40. Stewart R, Russ C, Richards M, Brayne C, Lovestone S, Mann A: Depression, APOE genotype and subjective memory impairment: a cross-sectional study in an African- Caribbean population. Psychol Med 2001; 3: 431-440. (Pubitemid 32294041)
41. Jonker C, Geerlings MI, Schmand B: Are memory complaints predictive for dementia? A review of clinical and populationbased studies. Int J Geriatr Psychiatry 2000; 11: 983-991.
42. Jessen F, Feyen L, Freymann K, Tepest R, Maier W, Heun R, Schild H-H, Scheef L: Volume reduction of the entorhinal cortex in subjective cognitive impairment. Neurobiol Aging 2006; 12: 1751-1756. (Pubitemid 44572584)
43. Stewart R, Dufouil C, Godin O, Ritchie K, Maillard P, Delcrix N, Crivello F, Mazoyer B, Tzourio C: Neuroimaging correlates of subjective memory deficits in a community population. Neurology 2008; 18: 1601-1607. (Pubitemid 351620315)
44. Mosconi L, De Santi S, Brys M, Tsui WH, Pirraglia E, Glodzik-Sobanska L, Rich KE, Switalski R, Mehta PD, Pratico D, Zinkowski R, Blennow K, de Leon MJ: Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints. Biol Psychiatry 2008; 6: 609-618. (Pubitemid 351273189)
45. Babiloni C, Visser PJ, Frisioni G, De Deyn PP, Bresciani L, Jelic V, Nagels G, Rodriguez G, Rossini PM, Vecchio F, Colombo D, Verhey F, Wahlund L-O, Nobili F: Cortical sources of resting EEG rhythms in mild cognitive impairment and subjective memory complaint. Neurobiol Aging 2010; 10: 1787-1798.
46. Visser PJ, Verhey F, Knol DL, Scheltens P, Wahlund LO, Freund-Levi Y, Tsolaki M, Minthon L, Wallin ÅK, Hampel H, Bürger K, Pirttila T, Soininen H, Rikkert MO, Verbeek MM, Spiru L, Blennow K: Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol 2009; 7: 595-596.